InspireMD (NSPR) Cash & Equivalents Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.70% |
| Sep 30, 2025 | 42.26% |
| Jun 30, 2025 | -3.65% |
| Mar 31, 2025 | 31.57% |
| Dec 31, 2024 | 27.96% |
| Sep 30, 2024 | 17.20% |
| Jun 30, 2024 | 42.55% |
| Mar 31, 2024 | 10.09% |
| Dec 31, 2023 | 0.54% |
| Sep 30, 2023 | 4.24% |
| Jun 30, 2023 | 12.38% |
| Mar 31, 2023 | -1.83% |
| Dec 31, 2022 | 4.54% |
| Sep 30, 2022 | -3.76% |
| Jun 30, 2022 | -1.45% |
| Mar 31, 2022 | -1.87% |
| Dec 31, 2021 | 9.82% |
| Sep 30, 2021 | 4.52% |
| Jun 30, 2021 | 115.80% |
| Mar 31, 2021 | 85.61% |
| Dec 31, 2020 | 31.17% |
| Sep 30, 2020 | 10.83% |
| Jun 30, 2020 | 7.25% |
| Dec 31, 2019 | -2.63% |
| Jun 30, 2019 | -11.71% |
| Mar 31, 2019 | -15.78% |
| Dec 31, 2018 | -11.75% |
| Sep 30, 2018 | 160.92% |
| Jun 30, 2018 | -15.35% |
| Mar 31, 2018 | 13.02% |
| Dec 31, 2017 | -7.35% |
| Sep 30, 2017 | -10.50% |
| Jun 30, 2017 | -7.73% |
| Mar 31, 2017 | 20.67% |
| Dec 31, 2016 | 8.09% |
| Sep 30, 2016 | 6.94% |
| Jun 30, 2016 | -35.73% |
| Mar 31, 2016 | -26.96% |
| Dec 31, 2015 | 38.63% |
| Sep 30, 2015 | 50.04% |
| Jun 30, 2015 | 92.45% |